Biovariance

Established in 2013 and headquartered in Tirschenreuth, Germany, BioVariance GmbH is dedicated to improving patient health and quality of life through the interdisciplinary analysis and interpretation of medical data. The company employs a team of experts, including data analysts, software developers, chemists, and biologists, who collaborate to develop precise diagnostics and therapies, particularly for complex diseases such as cancer. 

BioVariance's services encompass various aspects of personalized medicine, including:

• Laboratory Services: Utilizing state-of-the-art equipment, such as mass spectrometers and sequencers, to conduct medical and veterinary analyses, method development, and biomarker discovery. 
• Data Science: Building individualized AI-supported data structures tailored to specific requirements, enabling the statistical evaluation, modeling, analysis, and visualization of research results. 
• Clinical Trials: Offering comprehensive solutions from sample collection to final reporting, with an extensive biobank and a network of experts to facilitate tailored studies. 

Committed to innovation, BioVariance participates in international research projects, such as the EU-funded "BEATsep" initiative, aiming to combat the long-term effects of sepsis. 

By integrating cutting-edge technology with scientific expertise, BioVariance strives to make biomedical variance quantifiable and actively applicable in disease treatment, paving the way for advancements in personalized medicine.